• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾地区遗传性甲状腺素运载蛋白Ala97Ser相关淀粉样变性(ATTR)的表型表达

Phenotypic expressions of hereditary Transthyretin Ala97Ser related Amyloidosis (ATTR) in Taiwanese.

作者信息

Hsu Hui-Ching, Liao Ming-Feng, Hsu Jung-Lung, Lo Ai-Lun, Kuo Hung-Chou, Lyu Rong-Kuo, Wu Victor Chien-Chia, Wang Chih-Wei, Ro Long-Sun

机构信息

Department of Traditional Chinese Medicine, Division of Chinese Acupuncture and Traumatology, Chang Gung Memorial Hospital Linkou Medical Center and Chang Gung University College of Medicine, No.5, Fuxing St., Guishan Dist, Taoyuan City, 333, Taiwan, Republic of China.

Department of Neurology, Chang Gung Memorial Hospital Linkou Medical Center and Chang Gung University College of Medicine, No.199, Tung Hwa N. Rd., Songshan Dist, Taipei City, 105, Taiwan, Republic of China.

出版信息

BMC Neurol. 2017 Sep 7;17(1):178. doi: 10.1186/s12883-017-0957-4.

DOI:10.1186/s12883-017-0957-4
PMID:28882124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5590125/
Abstract

BACKGROUND

The disease course and early signs specific to ATTR Ala97Ser, the most common endemic mutation in Taiwan, have not been well described. Since new medications can slow down the rate of disease progression, the early diagnosis of this heterogeneous and fatal disease becomes critical.

METHODS

We retrospectively reviewed the characteristics of genetically confirmed ATTR Ala97Ser patients at a tertiary referral medical center.

RESULTS

Eight patients from 7 different families were enrolled (61.7 ± 5.5 years). Gastrointestinal symptoms, dyspnea or chest tightness, rather than sensory symptoms, were the initial symptoms in two patients (2/7 = 29%). Body weight loss (3/7 = 43%), muscle wasting (4/7 = 57%), or dysphagia (3/7 = 43%) were the consecutive symptoms. Orthostatic symptoms including orthostatic hypotension (7/7 = 100%), dizziness (6/7 = 86%) and syncope (5/7 = 71%) tended to develop in the late phase of the disease. Autonomic dysfunction was conspicuous. Cardiographic findings included a combination of ventricular wall thickening and pericardial effusion (7/7 = 100%), a granular sparkling appearance of the ventricular myocardium (4/7 = 57%), or conduction abnormalities (5/7 = 71%).

CONCLUSIONS

This study broadens the recognition of the initial signs and symptoms, including cardiographic findings and longitudinal manifestations in Taiwanese individuals with ATTR Ala97Ser mutation. These manifestations should prompt doctors to perform further studies and make an early diagnosis.

摘要

背景

台湾最常见的地方性突变ATTR Ala97Ser的疾病进程和早期体征尚未得到充分描述。由于新药物可以减缓疾病进展速度,因此对这种异质性致命疾病的早期诊断变得至关重要。

方法

我们回顾性分析了一家三级转诊医疗中心经基因确诊的ATTR Ala97Ser患者的特征。

结果

纳入了来自7个不同家庭的8名患者(年龄61.7±5.5岁)。两名患者(2/7 = 29%)的初始症状为胃肠道症状、呼吸困难或胸闷,而非感觉症状。随后出现体重减轻(3/7 = 43%)、肌肉萎缩(4/7 = 57%)或吞咽困难(3/7 = 43%)。直立性症状包括直立性低血压(7/7 = 100%)、头晕(6/7 = 86%)和晕厥(5/7 = 71%)往往在疾病后期出现。自主神经功能障碍较为明显。心电图表现包括室壁增厚和心包积液同时出现(7/7 = 100%)、心室心肌呈颗粒状闪烁外观(4/7 = 57%)或传导异常(5/7 = 71%)。

结论

本研究拓宽了对台湾携带ATTR Ala97Ser突变个体的初始体征和症状的认识,包括心电图表现和纵向表现。这些表现应促使医生进行进一步检查并做出早期诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310a/5590125/83876cf40483/12883_2017_957_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310a/5590125/becb324ad8c9/12883_2017_957_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310a/5590125/a41bd768138c/12883_2017_957_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310a/5590125/ef45c659bb2b/12883_2017_957_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310a/5590125/83876cf40483/12883_2017_957_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310a/5590125/becb324ad8c9/12883_2017_957_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310a/5590125/a41bd768138c/12883_2017_957_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310a/5590125/ef45c659bb2b/12883_2017_957_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310a/5590125/83876cf40483/12883_2017_957_Fig4_HTML.jpg

相似文献

1
Phenotypic expressions of hereditary Transthyretin Ala97Ser related Amyloidosis (ATTR) in Taiwanese.台湾地区遗传性甲状腺素运载蛋白Ala97Ser相关淀粉样变性(ATTR)的表型表达
BMC Neurol. 2017 Sep 7;17(1):178. doi: 10.1186/s12883-017-0957-4.
2
Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort.载脂蛋白 A97 丝氨酸转甲状腺素蛋白淀粉样变性相关性多发性神经病:泰国队列的临床和神经生理学特征。
BMC Neurol. 2021 May 22;21(1):206. doi: 10.1186/s12883-021-02243-3.
3
Clinical and genetic profiles of hereditary transthyretin amyloidosis in Taiwan.台湾遗传性转甲状腺素蛋白淀粉样变性的临床和遗传特征。
Ann Clin Transl Neurol. 2019 Apr 9;6(5):913-922. doi: 10.1002/acn3.778. eCollection 2019 May.
4
Hereditary Transthyretin Amyloidosis- Clinical and Genetic Characteristics of a Multiracial South-East Asian Cohort in Singapore.遗传性转甲状腺素蛋白淀粉样变性症-新加坡多民族东南亚队列的临床和遗传特征。
J Neuromuscul Dis. 2021;8(4):723-733. doi: 10.3233/JND-210656.
5
Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.遗传性转甲状腺素蛋白淀粉样变性在流行和非流行地区的遗传和临床特征:来自日本单一转诊中心的经验。
J Neurol. 2018 Jan;265(1):134-140. doi: 10.1007/s00415-017-8640-7. Epub 2017 Nov 24.
6
Hereditary transthyretin amyloidosis in mainland China: a unicentric retrospective study.中国大陆遗传性转甲状腺素蛋白淀粉样变性:一项单中心回顾性研究。
Ann Clin Transl Neurol. 2021 Apr;8(4):831-841. doi: 10.1002/acn3.51328. Epub 2021 Mar 19.
7
Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.与Pro24Ser转甲状腺素蛋白突变相关的遗传性心脏淀粉样变性:一例报告
J Med Case Rep. 2018 Dec 16;12(1):370. doi: 10.1186/s13256-018-1931-5.
8
Amyloid neuropathy with transthyretin mutations: overview and unique Ala97Ser in Taiwan.伴有转甲状腺素蛋白突变的淀粉样变神经病:概述及台湾地区独特的Ala97Ser突变
Acta Neurol Taiwan. 2011 Jun;20(2):155-60.
9
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis.遗传性转甲状腺素蛋白Ala97Ser相关淀粉样变性的基因分析
J Vis Exp. 2018 Jun 9(136):57743. doi: 10.3791/57743.
10
Transthyretin Ala97Ser in Chinese-Taiwanese patients with familial amyloid polyneuropathy: genetic studies and phenotype expression.中国台湾地区家族性淀粉样多神经病患者的转甲状腺素蛋白Ala97Ser:遗传学研究与表型表达
J Neurol Sci. 2008 Apr 15;267(1-2):91-9. doi: 10.1016/j.jns.2007.10.011. Epub 2007 Nov 26.

引用本文的文献

1
Real-World Characteristics and Treatment Patterns of Patients With Transthyretin Amyloid Cardiomyopathy: Protocol for a Multicountry Disease Registry Study.转甲状腺素蛋白淀粉样变心肌病患者的真实世界特征与治疗模式:一项多国疾病登记研究方案
JMIR Res Protoc. 2025 Jun 6;14:e71314. doi: 10.2196/71314.
2
Clinical features of hereditary transthyretin amyloidosis-polyneuropathy with transthyretin Ala97Ser(p.Ala117Ser) mutation in South Mainland China.中国华南地区遗传性转甲状腺素蛋白淀粉样变性多神经病伴转甲状腺素蛋白Ala97Ser(p.Ala117Ser)突变的临床特征
Orphanet J Rare Dis. 2025 Apr 28;20(1):202. doi: 10.1186/s13023-025-03733-0.
3

本文引用的文献

1
An Isolated Case of Late-onset Amyloidogenic Transthyretin Type Familial Amyloid Polyneuropathy Associated with a Mutant Transthyretin Substituting Methionine for Valine at Position 30 Showing Latent Progressive Cardiac Involvement Confirmed by Serial Annual Electrocardiograms.一例迟发性甲状腺素运载蛋白型家族性淀粉样多神经病孤立病例,与在第30位缬氨酸被甲硫氨酸替代的突变型甲状腺素运载蛋白相关,经连续年度心电图证实存在潜在进行性心脏受累。
Intern Med. 2017;56(2):163-168. doi: 10.2169/internalmedicine.56.7562. Epub 2017 Jan 15.
2
Elderly onset vitreous opacities as the initial manifestation in hereditary transthyretin (ATTR Val30Met) carries.
Ophthalmic Genet. 2017 Jul-Aug;38(4):387-391. doi: 10.1080/13816810.2016.1232413. Epub 2017 Jan 13.
3
Clinical measures in transthyretin familial amyloid polyneuropathy.转甲状腺素蛋白家族性淀粉样多神经病的临床指标
Associations of Patients with Pericardial Effusion Secondary to Light-Chain or Transthyretin Amyloidosis- A Systematic Review.
轻链或转甲状腺素蛋白淀粉样变性相关性心包积液患者的相关性:系统评价。
Curr Cardiol Rev. 2024;20(4):e080324227805. doi: 10.2174/011573403X280737240221060630.
4
Noninvasive multimodality imaging in hereditary transthyretin amyloid cardiomyopathy: a family case series from the southeast coast of China with an identified heterozygous missense mutation c.349G>T in the transthyretin gene.遗传性转甲状腺素蛋白淀粉样心肌病的非侵入性多模态成像:来自中国东南沿海的一个家系病例系列,其中转甲状腺素蛋白基因存在一个已鉴定的杂合错义突变c.349G>T 。
Quant Imaging Med Surg. 2023 Aug 1;13(8):5436-5442. doi: 10.21037/qims-23-39. Epub 2023 Jun 29.
5
2023 Expert Consensus of the Taiwan Society of Cardiology on the Diagnosis and Treatment of Cardiac Amyloidosis.台湾心脏病学会2023年心脏淀粉样变诊断与治疗专家共识
Acta Cardiol Sin. 2023 Jul;39(4):511-543. doi: 10.6515/ACS.202307_39(4).20230610A.
6
Natural history and survival rate of familial amyloidosis with polyneuropathy: A nationwide databank.家族性淀粉样多发性神经病的自然病史和生存率:全国数据库。
Ann Clin Transl Neurol. 2023 May;10(5):779-786. doi: 10.1002/acn3.51765. Epub 2023 Apr 12.
7
Clinical and biochemical characterization of hereditary transthyretin amyloidosis caused by E61K mutation.由E61K突变引起的遗传性转甲状腺素蛋白淀粉样变性的临床和生化特征
Front Mol Neurosci. 2022 Oct 12;15:1003303. doi: 10.3389/fnmol.2022.1003303. eCollection 2022.
8
Clinical Profile and Prognosis of Hereditary Transthyretin Amyloid Cardiomyopathy: A Single-Center Study in South China.遗传性转甲状腺素蛋白淀粉样变心肌病的临床特征与预后:中国南方单中心研究
Front Cardiovasc Med. 2022 Jun 27;9:900313. doi: 10.3389/fcvm.2022.900313. eCollection 2022.
9
Clinical recommendations to diagnose and monitor patients with transthyretin amyloid cardiomyopathy in Asia.亚洲诊断和监测转甲状腺素蛋白淀粉样心肌病患者的临床建议。
Clin Cardiol. 2022 Sep;45(9):898-907. doi: 10.1002/clc.23882. Epub 2022 Jul 6.
10
Gly83Arg Mutation: Beyond Familial Vitreous Amyloidosis.甘氨酸83位点精氨酸突变:超越家族性玻璃体淀粉样变性
Front Neurol. 2022 Feb 3;12:821003. doi: 10.3389/fneur.2021.821003. eCollection 2021.
Muscle Nerve. 2017 Mar;55(3):323-332. doi: 10.1002/mus.25257. Epub 2016 Dec 16.
4
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.非活检诊断心脏转甲状腺素淀粉样变性。
Circulation. 2016 Jun 14;133(24):2404-12. doi: 10.1161/CIRCULATIONAHA.116.021612. Epub 2016 Apr 22.
5
The role of echocardiography in the non-invasive diagnosis of cardiac amyloidosis.超声心动图在心脏淀粉样变性无创诊断中的作用。
J Echocardiogr. 2015 Sep;13(3):84-9. doi: 10.1007/s12574-015-0249-1. Epub 2015 Jul 14.
6
Sudomotor innervation in transthyretin amyloid neuropathy: Pathology and functional correlates.转甲状腺素蛋白淀粉样变神经病中的汗腺运动神经支配:病理学与功能关联
Ann Neurol. 2015 Aug;78(2):272-83. doi: 10.1002/ana.24438. Epub 2015 Jul 1.
7
A new prion disease: relationship with central and peripheral amyloidoses.一种新的朊病毒病:与中枢和周围淀粉样变性的关系。
Nat Rev Neurol. 2015 Feb;11(2):90-7. doi: 10.1038/nrneurol.2014.263. Epub 2015 Jan 27.
8
A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis.心脏淀粉样变病晚期植入式心脏节律记录器的研究。
Eur Heart J. 2015 May 7;36(18):1098-105. doi: 10.1093/eurheartj/ehu506. Epub 2014 Dec 29.
9
Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy.晚发性进行性转甲状腺素相关淀粉样变神经病的诊断要点和陷阱。
J Neurol. 2013 Dec;260(12):3093-108. doi: 10.1007/s00415-013-7124-7. Epub 2013 Oct 8.
10
Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy.塔法米迪治疗转甲状腺素蛋白家族性淀粉样多发性神经病的长期疗效。
J Neurol. 2013 Nov;260(11):2802-14. doi: 10.1007/s00415-013-7051-7. Epub 2013 Aug 22.